Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review
Cancer Reports · 2024-01 · 7 (1)
DOI: 10.1002/cnr2.1948 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, online erschienen am 08.12.2023. Verfasst von Md Rezoan Hossain und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology, Rajshahi University, Rajshahi, Bangladesh. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The growing complexity of cancer has made it a significant concern in the medical community. Although cancer research has advanced, it is still challenging to create new effective medications due to the limitations and side effects of existing treatment strategies. These are enforcing the development of some alternative drugs from natural compounds with fewer drawbacks and side effects.
Aim
Therefore, this review aims to provide up‐to‐date, crucial, and all‐encompassing data on esculetin's anticancer activity, including all relevant molecular and cellular processes based on in vivo and in vitro investigations.
Results
According to the literature review, esculetin is available in nature and is effective against 16 different types of cancer. The general mechanism shown by esculetin is modulating signaling cascades and its related pathways, like cell proliferation, cell growth, autophagy, apoptosis, necrosis, inflammation, angiogenesis, metastasis, invasion, and DNA damage. Nanoformulation of esculetin improves this natural product's efficacy by improving water solubility. Esculetin's synergistic effects with both natural substances and conventional treatments have been shown, and this method aids in reversing resistance mechanisms by modulating resistance‐related proteins. In addition, it has fewer side effects on humans than other phytochemicals and standard drugs with some good pharmacokinetic features.
Conclusion
Therefore, until standard chemotherapeutics are available in pharmaceutical markets, esculetin should be used as a therapeutic drug against various cancer types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Biology, Rajshahi University, Rajshahi, Bangladesh.
- Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
- Department of Medical, Dinajpure Nursing College (Affiliated Rajshahi University), Dinajpur, Bangladesh.
- Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
- Department of Pharmacy, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
- Departmnet of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
ORCID-Profile: Munira Haque, Md Sohel
Zitieren
APA
Rezoan Hossain, M., Zahra Shova, F. T., Akter, M., Shuvo, S., Ahmed, N., Akter, A., Haque, M., Salma, U., Roman Mogal, M., Saha, H. R., Sarkar, B. C., & Sohel, M. (2024). Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review. Cancer Reports, 7(1). https://doi.org/10.1002/cnr2.1948
Vancouver
Rezoan Hossain M, Zahra Shova FT, Akter M, Shuvo S, Ahmed N, Akter A, et al. Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review. Cancer Reports. 2024;7(1). doi:10.1002/cnr2.1948
BibTeX
@article{RezoanHossain2024,
author = {Rezoan Hossain, Md and Zahra Shova, Fatema Tuj and Akter, Munni and Shuvo, Shahporan and Ahmed, Nasim and Akter, Afroza and Haque, Munira and Salma, Umme and Roman Mogal, Md and Saha, Hasi Rani and Sarkar, Bidhan Chandra and Sohel, Md},
title = {Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review},
journal = {Cancer Reports},
year = {2024},
volume = {7},
number = {1},
doi = {10.1002/cnr2.1948}
}
EUVIMED